For press inquiries click here to contact us.
Eikon Therapeutics
Eikon Therapeutics Raises $350.7M in Series D Funding
Alumis, Inc. (Alumni)
Alumis and Kaken Pharma ink deal for ESK-001 in dermatology in Japan
Alumis, Inc. (Alumni)
ESK-001: A Conversation with Jörn Drappa, MD, PhD, of Alumis on Breakthrough Data and the Future of Psoriasis Treatment
Alumis, Inc. (Alumni)
AAD25: Ahead of Acelyrin merger, Alumis flexes mid-stage data for oral TYK2 inhibitor in psoriasis
Genomics PLC
Bupa to offer first genetic test for disease prediction in UK
Avenzo Therapeutics (Alumni)
Exclusive: Avenzo picks up another ADC, this time with multi-partnered DualityBio
Element Biosciences
Element Biosciences AVITI Sequencing
Xaira Therapeutics
Eye On AI: Funding To Biotech And Healthcare Startups Using AI Takes Off After Dip In 2023
Sollis Health
Sollis Health: Concierge Medicine Provider Company Secures $33 Million (Series B)
Please see important disclaimers in the Terms section.
